EDIT vs NTLA
EDIT 与 NTLA 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | EDITEditas Medicine, Inc. | NTLAINTELLIA THERAPEUTICS, INC. |
|---|---|---|
| 市值 | $258.47M | $1.50B |
| 市销率 | 6.4x | 22.2x |
| 营收同比增长 | 25.4% | 16.9% |
| 净利同比增长 | 32.5% | 20.5% |
| 息税前利润率 | -394.9% | -651.7% |
| 净资产收益率 | -3631.1% | -66.5% |
| 一年总回报 | +8.0% | -6.2% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:EDIT vs NTLA
| 指标 | EDIT | NTLA |
|---|---|---|
| 期末价值 | $880 | $4.9K |
| 总回报 | -91.2% | -51.3% |
| 年化收益 (CAGR) | -21.1% | -6.8% |
| 波动率 | 83.5% | 78.4% |
| 夏普比率 | 0.07 | 0.25 |
| 索提诺比率 | 0.11 | 0.37 |
| 最大回撤 | -98.9% | -96.5% |
基于 2574 个共同交易日,2016-05-06 → 2026-08-03 · 无风险利率 3.91%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)